Telik's US shares dive on drug admission

Telik's US shares dive on drug admission

There are 1 comment on the The Age story from Dec 26, 2006, titled Telik's US shares dive on drug admission. In it, The Age reports that:

Telik Inc has announced that its experimental cancer drug failed to improve survival in patients with advanced lung cancer or in patients with ovarian cancer, sending its stock plunging 70 per cent.

Join the discussion below, or Read more at The Age.

Dmitriy

Weatherly, PA

#1 Dec 26, 2006
What were the results of all of the trials?

http://www.refuter.com

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Telik Discussions

Title Updated Last By Comments
News Telik's Drug Problem (Jun '07) Jun '07 MHL5723 1
News Cancer Drug Fails Test, and the Company's Stock... (Dec '06) Dec '06 gdpawel 1